(Q34616168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Inhibitors of indoleamine 2,3-dioxygenase: a review of novel patented lead compounds (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

0 references

Raimondo De Cristofaro

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sergio Rutella

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

Silvio Danese

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Tiziana Di Pucchio

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

1 February 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Patents

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

229-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

IDO expression by dendritic cells: tolerance and tryptophan catabolism

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Prevention of allogeneic fetal rejection by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Regulatory T cells in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Emerging concepts in CD8(+) T regulatory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Altered macrophage differentiation and immune dysfunction in tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

NKT cells in immunoregulation of tumor immunity: a new immunoregulatory axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Mast cells are essential intermediaries in regulatory T-cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Tolerogenic dendritic cells: cytokine modulation comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The terminology issue for myeloid-derived suppressor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cutting edge: human eosinophils regulate T cell subset selection through indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Targeting indoleamine 2,3-dioxygenase (IDO) to counteract tumour-induced immune dysfunction: from biochemistry to clinical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Immune escape as a fundamental trait of cancer: focus on IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase and tumor-induced tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase-2; a new enzyme in the kynurenine pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Reconstructing eukaryotic NAD metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

T cell apoptosis by tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

A two-step induction of indoleamine 2,3 dioxygenase (IDO) activity during dendritic-cell maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The concentration of kynurenine in rat model of asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Analysis of transcription factors regulating induction of indoleamine 2,3-dioxygenase by IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Multiple female reproductive failures in cyclooxygenase 2-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cyclooxygenase-2 inhibitor enhances the efficacy of a breast cancer vaccine: role of IDO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Targeting cyclooxygenase-2 in human neoplasia: rationale and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of interferon-mediated induction of indoleamine 2,3-dioxygenase in mouse lung by inhibitors of prostaglandin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Regulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Modulation of cellular tryptophan metabolism in human fibroblasts by transforming growth factor-beta: selective inhibition of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA synthetase gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

TGF-beta and kynurenines as the key to infectious tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

A high-affinity, tryptophan-selective amino acid transport system in human macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Nanosensor detection of an immunoregulatory tryptophan influx/kynurenine efflux cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Modulation of invariant natural killer T cell cytokine responses by indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cell-autonomous control of interferon type I expression by indoleamine 2,3-dioxygenase in regulatory CD19+ dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Modulation of tryptophan catabolism by regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Th17: an effector CD4 T cell lineage with regulatory T cell ties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

IDO and tolerance to tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase serves as a marker of poor prognosis in gene expression profiles of serous ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

IDO recruits Tregs in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Synovial autoreactive T cells in rheumatoid arthritis resist IDO-mediated inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase expression promotes renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Kynurenines and oxidative status are independently associated with thrombomodulin and von Willebrand factor levels in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Blockade of indoleamine 2,3-dioxygenase protects mice against lipopolysaccharide-induced endotoxin shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase activity associates with cardiovascular risk factors: the Health 2000 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase enzyme activity correlates with risk factors for atherosclerosis: the Cardiovascular Risk in Young Finns Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-asociated cells: implications for persistent Chlamydophila pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Kynurenic acid triggers firm arrest of leukocytes to vascular endothelium under flow conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Elevated Expression of indoleamine 2,3-dioxygenase (IDO) and accumulation of kynurenic acid in the pathogenesis of STZ-induced diabetic cataract in Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase overexpression causes kynurenine-modification of proteins, fiber cell apoptosis and cataract formation in the mouse lens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase is a critical regulator of acute graft-versus-host disease lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Nonimmune cells in inflammatory bowel disease: from victim to villain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Deficiency of indoleamine 2,3-dioxygenase enhances commensal-induced antibody responses and protects against Citrobacter rodentium-induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase in infection: the paradox of an evasive strategy that benefits the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Severe tryptophan starvation blocks onset of conventional persistence and reduces reactivation of Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Regulatory T-cell markers, indoleamine 2,3-dioxygenase, and virus levels in spleen and gut during progressive simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in an animal model of HIV-1 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Combined effect of antiretroviral therapy and blockade of IDO in SIV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Chronic effects of γ-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The excitotoxin quinolinic acid induces tau phosphorylation in human neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Parameters of soluble immune activation in vivo correlate negatively with the proliferative capacity of peripheral blood mononuclear cells in vitro in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Marrying immunotherapy with chemotherapy: why say IDO?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Manipulation of indoleamine 2,3 dioxygenase; a novel therapeutic target for treatment of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase expression is restricted to fetal trophoblast giant cells during murine gestation and is maternal genome specific

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

1-Methyl-DL-tryptophan, beta-(3-benzofuranyl)-DL-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-DL-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Targeting the mechanisms of tumoral immune tolerance with small-molecule inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Toxicology and pharmacokinetics of 1-methyl-d-tryptophan: absence of toxicity due to saturating absorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

IRF-7 is the master regulator of type-I interferon-dependent immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Levo- but not dextro-1-methyl tryptophan abrogates the IDO activity of human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Twelve immunotherapy drugs that could cure cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Inhibition of indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by beta-carboline and indole derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Enzyme kinetic and spectroscopic studies of inhibitor and effector interactions with indoleamine 2,3-dioxygenase. 1. Norharman and 4-phenylimidazole binding to the enzyme as inhibitors and heme ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

(-)-Epigallocatechin gallate suppresses indoleamine 2,3-dioxygenase expression in murine dendritic cells: evidences for the COX-2 and STAT1 as potential targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Novel N-hydroxyguanidine derivatives as anticancer and antiviral agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Biomimetic synthesis of the IDO inhibitors exiguamine A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Immunomodulatory effects of Turkish propolis: changes in neopterin release and tryptophan degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Curcumin suppresses the induction of indoleamine 2,3-dioxygenase by blocking the Janus-activated kinase-protein kinase Cdelta-STAT1 signaling pathway in interferon-gamma-stimulated murine dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The immunoregulatory role of IDO-producing human dendritic cells revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

T cells, B cells, and polarized immune response in the pathogenesis of fibrosis and systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

IDO: a double-edged sword for T(H)1/T(H)2 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543770903512974

10.1517/13543770903512974

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20100004%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference